Rockefeller Capital Management
NAUT icon

Rockefeller Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Rockefeller Capital Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6K Buy
9,400
+3,200
+52% +$8.45K ﹤0.01% 3774
2026
Q1 		$24.1K Buy
6,200
+1,200
+24% +$2.95K ﹤0.01% 3633
2025
Q4 		$9.75K Hold
5,000
– – ﹤0.01% 3816
2025
Q3 		$4.22K Buy
+5,000
New +$3.67K ﹤0.01% 3917
2022
Q2 		– Sell
-2,000
Closed -$8K – 4295
2022
Q1 		$8K Hold
2,000
– – ﹤0.01% 3165
2021
Q4 		$10K Buy
2,000
+1,000
+100% +$5.35K ﹤0.01% 2981
2021
Q3 		$6K Hold
1,000
– – ﹤0.01% 3110
2021
Q2 		$10K Hold
1,000
– – ﹤0.01% 2779
2021
Q1 		$13K Hold
1,000
– – ﹤0.01% 2484
2020
Q4 		$10K Buy
1,000
+500
+100% +$5.27K ﹤0.01% 2239
2020
Q3 		$5K Buy
+500
New +$5.33K ﹤0.01% 2232

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Rockefeller Capital Management's NAUT Position: Q2 2026 in Review

Rockefeller Capital Management increased its Nautilus Biotechnolgy (NAUT) stake by 52% in Q2 2026, buying an estimated $8.45K and bringing the position to 9,400 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3774.

Rockefeller Capital Management first reported a position in NAUT in Q3 2020 and has held it in 11 quarters since. The position peaked at $24.1K in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Rockefeller Capital Management held 9,400 shares of Nautilus Biotechnolgy worth $17.6K as of Q2 2026.
  • Rockefeller Capital Management bought 3,200 Nautilus Biotechnolgy shares in Q2 2026, an estimated $8.45K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3774 holding.
  • Rockefeller Capital Management first reported a position in Nautilus Biotechnolgy in Q3 2020 and has held it in 11 quarters since.
  • Rockefeller Capital Management's Nautilus Biotechnolgy position peaked at $24.1K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.